Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2001;38:958-961
doi: 10.1161/hy1001.096362
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mourad, J.-J.
Right arrow Articles by Warzocha, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mourad, J.-J.
Right arrow Articles by Warzocha, U.
Related Collections
Right arrow Clinical Studies
Right arrow Epidemiology

(Hypertension. 2001;38:958.)
© 2001 American Heart Association, Inc.


Fourth Workshop on Structure and Function of Large Arteries

Conventional Antihypertensive Drug Therapy Does Not Prevent the Increase of Pulse Pressure With Age

Jean-Jacques Mourad; Jacques Blacher; Patrick Blin; Ursula Warzocha; on behalf of the investigators of the PHASTE study*

From the Department of Internal Medicine, St Michel Hospital (J.J.M., U.W.); the Department of Internal Medicine, Broussais Hospital (J.B.); and ICARE (P.B.), Paris, France.

Reprint requests to Dr Jean-Jacques Mourad, Department of Internal Medicine, St Michel Hospital, 33 rue Olivier de Serres, 75015 Paris, France. E-mail jean-jacques.mourad{at}hopital-saint-michel.org

Abstract

Abstract— Increased pulse pressure (PP), an independent predictor of cardiovascular risk, may be quantified on the basis of the prevalence of isolated systolic hypertension (ISH) in the population at large. The purpose of this study was to estimate the prevalence of ISH and its relation to age and drug therapy in a large group of outpatient hypertensive subjects in France. Between March and December 1999, 2975 French general practitioners included 17 716 consecutive patients with uncontrolled hypertension (systolic blood pressure [SBP] >140 mm Hg and/or diastolic blood pressure [DBP] >90 mm Hg), either treated or not treated. They were asked to complete a questionnaire concerning associated cardiovascular risk factors and ongoing antihypertensive therapy. Subjects were classified according to 5 age ranges (from 18 to 103 years). In each age range, SBP, DBP, mean blood pressure, and PP were significantly lower (P<0.001) in treated subjects than in untreated subjects, with the exception of PP in subjects >75 years. The latter finding resulted from a significant increase of SBP and PP with age, together with a significant lowering of DBP with age, irrespective of drug treatment. Subsequently, the prevalence of ISH increased with age from 20.4% to 35.2% in men and women. In any given age range, drug therapy for hypertension is associated with marginally lower values of PP. In the studied populations, the increase of PP with age is independent of gender and of the presence of antihypertensive drug treatment, leading to an increased prevalence of ISH and a subsequent increase of cardiovascular risk with age.


Key Words: hypertension, essential • antihypertensive therapy • blood pressure • pulse




This article has been cited by other articles:


Home page
HypertensionHome page
S. J. Bielinski, A. I. Lynch, M. B. Miller, A. Weder, R. Cooper, A. Oberman, Y.-D. I. Chen, S. T. Turner, M. Fornage, M. Province, et al.
Genome-Wide Linkage Analysis for Loci Affecting Pulse Pressure: The Family Blood Pressure Program
Hypertension, December 1, 2005; 46(6): 1286 - 1293.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. J. Zieman, V. Melenovsky, and D. A. Kass
Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Arterioscler. Thromb. Vasc. Biol., May 1, 2005; 25(5): 932 - 943.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. H. Dao, R. Essalihi, C. Bouvet, and P. Moreau
Evolution and modulation of age-related medial elastocalcinosis: Impact on large artery stiffness and isolated systolic hypertension
Cardiovasc Res, May 1, 2005; 66(2): 307 - 317.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
G. S. Stokes, E. S. Barin, and K. L. Gilfillan
Effects of Isosorbide Mononitrate and AII Inhibition on Pulse Wave Reflection in Hypertension
Hypertension, February 1, 2003; 41(2): 297 - 301.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
H. W. Hense, W. Maziak, and J. Heidrich
Why is blood pressure control unsatisfactory--or is it?
Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1547 - 1550.
[Full Text] [PDF]